396 related articles for article (PubMed ID: 25522423)
21. Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight.
Freudenreich O; Cather C; Evins AE; Henderson DC; Goff DC
J Clin Psychiatry; 2004 Oct; 65(10):1372-6. PubMed ID: 15491241
[TBL] [Abstract][Full Text] [Related]
22. Adherence to depot versus oral antipsychotic medication in schizophrenic patients during the long-term therapy.
Stanković Z; Ille T
Vojnosanit Pregl; 2013 Mar; 70(3):267-73. PubMed ID: 23607237
[TBL] [Abstract][Full Text] [Related]
23. Early perception of medication benefit predicts subsequent antipsychotic response in schizophrenia: "the consumer has a point" revisited.
Ascher-Svanum H; Weiden P; Nyhuis AW; Faries DE; Stauffer V; Kollack-Walker S; Kinon BJ
Clin Schizophr Relat Psychoses; 2014 Jul; 8(2):84-90, 90A. PubMed ID: 23446198
[TBL] [Abstract][Full Text] [Related]
24. Treatment adherence and insight in schizophrenia.
Bitter I; Fehér L; Tényi T; Czobor P
Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
[TBL] [Abstract][Full Text] [Related]
25. Compliance in schizophrenia: psychopathology, side effects, and patients' attitudes toward the illness and medication.
Rettenbacher MA; Hofer A; Eder U; Hummer M; Kemmler G; Weiss EM; Fleischhacker WW
J Clin Psychiatry; 2004 Sep; 65(9):1211-8. PubMed ID: 15367047
[TBL] [Abstract][Full Text] [Related]
26. How do socio-demographic and clinical factors interact with adherence attitude profiles in schizophrenia? A cluster-analytical approach.
Beck EM; Cavelti M; Wirtz M; Kossowsky J; Vauth R
Psychiatry Res; 2011 May; 187(1-2):55-61. PubMed ID: 21074860
[TBL] [Abstract][Full Text] [Related]
27. Attitudes Toward Medications and the Relationship to Outcomes in Patients with Schizophrenia.
Campbell AH; Scalo JF; Crismon ML; Barner JC; Argo TR; Lawson KA; Miller A
Clin Schizophr Relat Psychoses; 2018; 12(1):12-22. PubMed ID: 26218237
[TBL] [Abstract][Full Text] [Related]
28. A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia.
Ascher-Svanum H; Zhu B; Faries D; Lacro JP; Dolder CR
J Clin Psychiatry; 2006 Jul; 67(7):1114-23. PubMed ID: 16889456
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with antipsychotic medication adherence in community-based patients with schizophrenia in Hong Kong: a cross sectional study.
Bressington D; Mui J; Gray R
Int J Ment Health Nurs; 2013 Feb; 22(1):35-46. PubMed ID: 22738372
[TBL] [Abstract][Full Text] [Related]
30. Twelve months of electronic monitoring (MEMS®) in the Swedish COAST-study: a comparison of methods for the measurement of adherence in schizophrenia.
Brain C; Sameby B; Allerby K; Lindström E; Eberhard J; Burns T; Waern M
Eur Neuropsychopharmacol; 2014 Feb; 24(2):215-22. PubMed ID: 24359935
[TBL] [Abstract][Full Text] [Related]
31. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of adherence patterns in schizophrenia using electronic monitoring (MEMS®): A six-month post-discharge prospective study.
Misdrahi D; Tessier A; Husky M; Lange AC; Vrijens B; Llorca PM; Baylé FJ
Schizophr Res; 2018 Mar; 193():114-118. PubMed ID: 28663027
[TBL] [Abstract][Full Text] [Related]
33. Antipsychotic medication adherence and satisfaction among Palestinian people with schizophrenia.
Sweileh WM; Ihbesheh MS; Jarar IS; Sawalha AF; Abu Taha AS; Zyoud SH; Morisky DE
Curr Clin Pharmacol; 2012 Feb; 7(1):49-55. PubMed ID: 22299769
[TBL] [Abstract][Full Text] [Related]
34. The influence of adherence to antipsychotics medication on the quality of life among patients with schizophrenia in Indonesia.
Endriyani L; Chien CH; Huang XY; Chieh-Yu L
Perspect Psychiatr Care; 2019 Apr; 55(2):147-152. PubMed ID: 29578605
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study.
Graff-Guerrero A; Rajji TK; Mulsant BH; Nakajima S; Caravaggio F; Suzuki T; Uchida H; Gerretsen P; Mar W; Pollock BG; Mamo DC
JAMA Psychiatry; 2015 Sep; 72(9):927-34. PubMed ID: 26131622
[TBL] [Abstract][Full Text] [Related]
36. Treatment patterns and clinical characteristics prior to initiating depot typical antipsychotics for nonadherent schizophrenia patients.
Ascher-Svanum H; Peng X; Faries D; Montgomery W; Haddad PM
BMC Psychiatry; 2009 Jul; 9():46. PubMed ID: 19640279
[TBL] [Abstract][Full Text] [Related]
37. Insight and medication adherence in schizophrenia: An analysis of the CATIE trial.
Kim J; Ozzoude M; Nakajima S; Shah P; Caravaggio F; Iwata Y; De Luca V; Graff-Guerrero A; Gerretsen P
Neuropharmacology; 2020 May; 168():107634. PubMed ID: 31077729
[TBL] [Abstract][Full Text] [Related]
38. [RÉALITÉ LT, a pharmacoepidemiological study of semiology and therapeutic strategy of patients with schizophrenia treated by antipsychotic loxapine in routine clinical practice].
Cousin FR; Samuelian JC; Saoud M; Schmitt L; Vacheron MN; Vidailhet P; Augendre J; Walter M; Tonelli I; Pascal JC
Encephale; 2012 Feb; 38(1):64-74. PubMed ID: 22381726
[TBL] [Abstract][Full Text] [Related]
39. [Strategies for measuring medication adherence in patients with schizophrenia].
Wang Y; Huang Z; Xu D; Gong W; Tang Y; Xiao S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 41(2):218-24. PubMed ID: 26932222
[TBL] [Abstract][Full Text] [Related]
40. Attitudes toward antipsychotics among outpatient clinic attendees with schizophrenia.
Hofer A; Kemmler G; Eder U; Honeder M; Hummer M; Fleischhacker WW
J Clin Psychiatry; 2002 Jan; 63(1):49-53. PubMed ID: 11838626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]